Jitendra Sriram, MD & Head of Research of HSBC India is of the view that one may prefer Sun Pharmaceutical and Lupin from the pharma space.
first published: Sep 18, 2013 11:23 am
A collection of the most-viewed Moneycontrol videos.

Small town, Big tech: Sridhar Vembu on Zoho’s rural push, AI Bubble, SaaS consolidation & many more

Live: DAVOS 2026 Day 5 Highlights: Elon Musk, AI Innovations & India’s Investment Pitch

Budget 2026 Decoded ? Key Terms You Must Know | Inflation, Taxes & Spending

Live: Sensex tumbles 2,000 pts this week, Nifty gives up 25,100 | Closing Bell
You are already a Moneycontrol Pro user.

